Landmark: Sanofi announces to reduce price of TB drug Rifapentine by 70 percent Medical Dialogues Bureau1 Nov 2019 3:29 PM ISTScale-up of affordable Rifapentine stands to benefit over a million people in India alone, where more people suffer from TB than anywhere else in the...
JnJ enters series of new collaborations with Government, NGOs for ending TB in India by 2025 Farhat Nasim31 Oct 2019 12:39 PM ISTHyderabad: Johnson & Johnson(JnJ) recently announced the expansion of its tuberculosis (TB) program in India in advance of the 50th Union World...
Mylan moves application with DCGI to launch new TB drug Pretomanid in India Medical Dialogues Bureau16 Oct 2019 4:10 PM IST"We have submitted the new drug application to the office of DCGI. We are in an advanced stage of discussion and are working with the office of...
JnJ pledges USD 500 million investment to eliminate HIV, TB by 2030 Medical Dialogues Bureau7 Oct 2019 9:30 AM ISTNEW BRUNSWICK: Johnson & Johnson (JnJ) recently announced it has committed to ensuring more than $500 million is dedicated to world-class research...
Technical Committee recommends CDSCO to approve import, marketing of Sanofi TB drug with clinical trial waiver Farhat Nasim28 May 2019 4:21 PM ISTNew Delhi: Apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has been recommended by the Techincal Committee to granted...
Union Health Minister asked not to receive donations from JnJ for TB Control Program Medical Dialogues Bureau3 May 2019 9:15 AM ISTRecently, Johnson & Johnson (JnJ) had announced to provide an additional 10,000 courses of tuberculosis drug bedaquiline (BDQ) to the Indian...
Mylan, TB Alliance to commercialize Pretomanid to treat TB Farhat Nasim23 April 2019 10:00 AM ISTTB Alliance began preclinical development of pretomanid in 2002, and it has since studied pretomanid in 20 clinical trials alone or in combination...
Government must have compulsive licensing for essential drugs : Chairman, Cipla Farhat Nasim8 March 2019 9:30 AM ISTCipla Chairman, Y K Hamied said that many drugs which are not covered under patent should be made in India which is not happening at present, citing...
